Rubius Therapeutics, Inc. (RUBY)

Stock Price Forecast

According to 7 stock analysts, the average 12-month stock price forecast for RUBY stock is $1.02, which predicts an increase of 264.29%. The lowest target is $1.01 and the highest is $1.05. On average, analysts rate RUBY stock as a sell.

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$1.01	$1.02	$1.02	$1.05
Change	+260.71%	+264.29%	+264.29%	+275.00%

Analyst Ratings

The average analyst rating for RUBY stock from 7 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Aug '22	Sep '22	Oct '22	Nov '22	Dec '22	Jan '23
Strong Buy	4	4	3	3	0	0
Buy	4	4	4	3	0	0
Hold	4	4	5	4	4	4
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	2	2
Total	12	12	12	10	7	7

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -1.86

Year	2017	2018	2019	2020	2021	2022	2023
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-5.55	-2.27	-2.08	-2.08	-2.23	-1.86	-0.66
EPS Growth	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Revenue Forecast

Revenue	2022	2023
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2022	2023
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2022	2023
High	-1.89	-0.34
Avg	-1.86	-0.66
Low	-1.81	-0.96

EPS Growth

EPS Growth	2022	2023
High	-	-
Avg	-	-
Low	-	-

Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.